General Information of Drug (ID: DMAKR2E)

Drug Name
2-(phenylsulfonyl)naphthalene-1,4-diol Drug Info
Synonyms 2-(phenylsulfonyl)naphthalene-1,4-diol; CHEMBL462205; SCHEMBL9717678; YEDZIHZPRGSAMI-UHFFFAOYSA-N; BDBM50245877
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
15657226
TTD Drug ID
DMAKR2E

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Thiolactomycin DMBAWDG Malaria 1F40-1F45 Investigative [2]
2-(4-Bromo-3-phenoxy-benzoylamino)-benzoic acid DMY8GZP Discovery agent N.A. Investigative [3]
2-(4-Fluoro-3-phenoxy-benzoylamino)-benzoic acid DMGLEX5 Discovery agent N.A. Investigative [3]
2-Hydroxy-6-(3-phenoxy-benzoylamino)-benzoic acid DMB3Y8H Discovery agent N.A. Investigative [3]
2-Tosylnaphthalene-1,4-diol DM5FHO4 Discovery agent N.A. Investigative [1]
2-(p-tolylthio)naphthalene-1,4-dione DMON1A5 Discovery agent N.A. Investigative [1]
2-tosylnaphthalene DM2OUG0 Discovery agent N.A. Investigative [1]
2-(4-propylphenylsulfonyl)naphthalene-1,4-diol DMXC20R Discovery agent N.A. Investigative [1]
2-tosylanthracene-1,4-diol DMOFDVE Discovery agent N.A. Investigative [1]
2-(4-chlorophenylsulfonyl)naphthalene-1,4-diol DMJORCV Discovery agent N.A. Investigative [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Bacterial Beta-ketoacyl-ACP synthase III (Bact fabH) TTRVTMX FABH_ECOLI Inhibitor [1]

References

1 Synthesis and biological evaluation of novel sulfonyl-naphthalene-1,4-diols as FabH inhibitors. Bioorg Med Chem Lett. 2008 Dec 15;18(24):6402-5.
2 The apicoplast as an antimalarial drug target. Drug Resist Updat. 2001 Jun;4(3):145-51.
3 Structure-based design, synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III as potential antimicrobial age... J Med Chem. 2005 Mar 10;48(5):1596-609.